My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 449

    1.

    The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

    Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

    Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.PMID: 17317763 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice.

    Goudy KS, Wang B, Tisch R.

    Clin Immunol. 2008 Oct;129(1):49-57.PMID: 18675592 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.

    Li L, Yi Z, Wang B, Tisch R.

    J Immunol. 2009 Oct 1;183(7):4809-16. Epub 2009 Sep 14.PMID: 19752238 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.

    Weaver DJ Jr, Liu B, Tisch R.

    J Immunol. 2001 Jul 1;167(1):586-92.PMID: 11418698 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.

    Seifarth C, Pop S, Liu B, Wong CP, Tisch R.

    J Immunol. 2003 Jul 1;171(1):469-76.PMID: 12817032 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    7.

    Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?

    Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.

    Gene Ther. 2004 Oct;11(20):1487-96.PMID: 15343360 [PubMed - indexed for MEDLINE]Related articles

    8.

    Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.

    Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R.

    J Exp Med. 2005 Apr 18;201(8):1333-46.PMID: 15837817 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

    Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

    Diabetes. 1996 Oct;45(10):1350-7.PMID: 8826970 [PubMed - indexed for MEDLINE]Related articles

    10.

    Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.

    Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE.

    J Immunol. 2001 Mar 1;166(5):2982-91.PMID: 11207247 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.

    Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. Epub 2007 Mar 26.PMID: 17389382 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.

    Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, Kim SK, Dickie P, Teyton L, Davis M, McDevitt H.

    J Exp Med. 2002 Aug 19;196(4):481-92.PMID: 12186840 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    CD3 antibody treatment stimulates the functional capability of regulatory T cells.

    Chatenoud L.

    Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.PMID: 14609225 [PubMed - indexed for MEDLINE]Related articles

    14.

    Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination.

    Tisch R, Wang B, Weaver DJ, Liu B, Bui T, Arthos J, Serreze DV.

    J Immunol. 2001 Feb 1;166(3):2122-32.PMID: 11160264 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.

    Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M.

    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2821-6. Epub 2007 Feb 16.PMID: 17307871 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

    Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M, Davis M, McDevitt HO.

    Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14204-9. Epub 2004 Sep 20.PMID: 15381770 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

    Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

    Diabetes. 1999 Nov;48(11):2150-6.PMID: 10535448 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

    Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG.

    J Exp Med. 1998 Apr 6;187(7):1047-56.PMID: 9529321 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity